This study investigated the immunohistochemical expression of amelogenin (AMELX), odontogenic ameloblast-associated protein (ODAM), and cytokeratin 19 (CK19) in craniopharyngioma and ameloblastoma, aiming to shed light on their potential shared embryological origins and divergent pathological mechanisms. This evidence concerns the gene KRT19 and ameloblastoma.